Photo: JENS KALAENE
Pharmac has taken the first steps towards funding weight loss drug Wegovy after an advisory panel provisionally recommended funding it as a high priority for some people.
Wegovy or semaglutide is a GLP-
Continue Reading on RNZ
This preview shows approximately 15% of the article. Read the full story on the publisher's website to support quality journalism.